Lilly to Participate in Bernstein Operational Decisions Conference

INDIANAPOLIS , Nov. 12, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020 . Andrew Adams , Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly 's anti-COVID-19